
    
      This is a randomized, double-blind, placebo-controlled, sequential dose escalation study in
      diabetic subjects with a diabetic lower leg or foot ulcer. All subjects will receive
      standard-of-care ulcer treatment from screening through the last study visit.

      The study will be conducted at multiple investigational sites located in Taiwan. Additional
      sites and countries may be added during the course of the study if required.
    
  